TABLE 1

Provisional Radiation to Target Lesions and Bone Marrow

				Target lesions			Bone marrow
Patient no.	Disease	Stage	Radioimmunotherapy activity (GBq)	Site	mGy/MBq	Intended dose (Gy)	mGy/MBq	Intended dose (Gy)
1	SLL-NHL	IIIB	Not eligible	Left axillary LN	0.8	4.44	0.12	1.1
2	SLL-NHL	IIIBS	5.55	Left laterocervical LN	3.3	18.315	0.18	0.1
3	HL	IIIBS	5.55	Lung, right middle lobe	2.5	14	0.23	1.3
4	HL	IVB	3.7	Right lung, nodular lesion	0.9	3.33	0.19	0.69
				Chest wall,anterior mass	3.2	11.84
5	HL	IVB	3.7 (n = 5)	Left lung, basal nodular lesion	5.6	20.72	0.23	0.85
				Right axillary LN	1	3.7
6	HL	IVB	Not eligible	Lumboaortic LN	0.4	2	0.13	0.48
7	FL-NHL	IIIA	Not eligible	Left axillary LN	0.2	1.11	0.21	1.2
				Right axillary LN	0.1	0.555
				Right cervical LN	0.4	2.22
				Right inguinal LN	0.5	2.77
8	HL	IVB	Not eligible	Any	—	—	0.27	1.42
9	MM	III	3.7	—	—	—	0.24	0.9
10	MM	III	1.85	—	—	—	0.21	0.38
11	MM	III	Not applied, withdrew from study	—	—	—	0.43	1.58
12	HL	IVB	3.7 (n = 2)	Right paracardiac LN	20.7	76.59	0.19	0.72
13	HL	IVB	3.7	Right dorsal muscle	0.6	2.44	0.63	2.55
				Right axillary LN	2.5	10.17
14	HL	IVB	3.7 (n = 2)	Costopleural lesion	15.4	62.7	0.19	0.76
15	HL	IVB	3.7 (n = 2)	Aortopulmonary window LN	5.8	25.75	0.36	1.6
16	HL	IVB	Not applied, rapid progress	Mediastinal anterior mass	8.9	32.93	3.2	11.8
17	DLBCL	IIIA	3.7	Left inguinal LN	3.5	12.95	0.24	0.9
18	HL	IVB	1.85	Right iliac LN	3	5.55	0.22	0.34